ICD-9-CM Codesa | Equivalent ICD-10-CM Codesa | |
---|---|---|
For exclusion from study | ||
Gestational diabetes | 648.8x | O99.81x |
Pregnancy-related claims | V22.x-V24.x, V27.x, 630.xx-679.xx | Z33.x, Z34.xx, Z37.xx, Z39.x, O09.xxx, O60. xxxx-O77.x, O80, O82, O85-O92.xxx |
Type 1 diabetes | 250.x1, 250.x3 | E10.xxxx |
Comorbidities | ||
Type 2 diabetes | 250.x0, 250.x2 | E11.xxxx |
Anxiety | 300.0x | F41.x |
Depression | 296.2x, 296.3x, 311 | F32.xx, F33.xx |
Severe mental illness | ||
Bipolar disorder | 296.0x, 296.4x - 296.7x, 296.80, 296.89 | F30.1, F31.xx |
Psychotic disorders (organic) | 292.xx-294.xx | F19.xx, F05, F04 |
Psychotic disorders (nonorganic, nonaffective) | 295.xx, 297.xx, 298.xx | F20.xx, F22, F23, F28, F29, F33.3, F44.89 |
Hypertension | 401.xx-405.xx | I10-I.15x |
Hyperlipidemia | 272.0 - 272.4, 272.8, 272.9 | E78.xx |
Metabolic syndrome | 277.7 | E88.81 |
Coronary heart disease | 410.xx-411.xx, 412, 413.x-417.x, 427.xx, 429.2, 429.9 | I20.xx-I25.xxx, I50.xx |
Heart failure | 428.xx | I50.xx |
Diabetic retinopathy | 362.0x | E11.31x-E11.35xx |
Diabetic neuropathy | 357.2 | E11.4x |
Cerebrovascular disease | 433.x1, 434.x1, 435.9, 436, 437.1, 437.9 | |
Peripheral artery disease | 440.2x, 440.3x, 440.4, 440.8, 440.9 | I70.2xx-I70.9x |
Diabetic nephropathy | 250.40, 250.42 | E11.2xx |
Chronic kidney disease | 403.xx, 404.xx, 585.1-585.5, 585.9 | |
Chronic kidney disease | 585.x, 403.xx, 404.xx | N18.x, I12.x, I13.xx |
End-stage kidney disease | 585.6 | N18.6 |
Hypoglycemia | 251.0-251.2 | E11.64x |
Overweight | 278.02 | E66.3 |
Obesity | 278.00, 278.01 | E66.0x-E66.2, E66.8-E66.9 |
Diabetic counseling | ||
Lifestyle and medication counseling | V65.3, V58.67, V53.91, Z79.84 | Z71.3, Z79.4 |
CPT codes | G0108, G0109, 98960-98962, 97802-97804, 99078, S9140, S9141, S9145, S9455, S9460, S9465, S9470 | |
For aDCSI calculation | ||
Retinopathy | 250.5x, 361.xx, 362.01, 362.1, 362.83, 362.53, 362.81, 362.82, 362.02, 369.xx, 379.23 | E08.3x, E09.3x, E11.3x, E13.3x, H35.0x, H35.35x, H35.6x, H35.8x, H35.9, H33.x, H54.x, H43.1x |
Nephropathy | 250.4, 580, 581, 581.81, 582, 583, 585, 586, 593.9 | E08.21, E08.22, E08.29, E09.21, E09.22, E09.29, E11.21, E11.22, E11.29, E13.21, E13.22, E13.29, N00.x, N03.x-N05.x, N18.1, N18.2-N18.6, N18.9, N19 |
Neuropathy | 356.9, 250.6, 358.1, 951.0, 951.1, 951.3, 357.2 | E08.4x, E09.4x, E11.4x, E13.4x, G56.x, G57.x, G60.9, G73.3, G90.09, G90.1, G90.8, G90.9, G99.0, H49.x, I95.1, K31.84, K59.1, N31.9, M14.6x, S04.x |
Cerebrovascular | 431, 433, 434-436 | G45.x, I61.x, I63.x, I65.x, I66.x, I67.81 |
Cardiovascular | 410-414, 427.1, 427.3-427.5, 428, 429.2, 440.xx, 441 | I20.x-I25.x, I46.x-I50.x, I70.x, I71.x |
Peripheral vascular disease | 040.0, 250.7, 442.3, 443.81, 443.9, 444.22, 785.4, 707.1, 892.1 | E08.51, E08.59, E08.621, E09.51, E09.59, E09.621, E11.51, E11.59, E11.621, E13.51, E13.59, E13.621, I72.4, I70.21, I73.89, I73.9, I74.3, S91.3x, A48.0, L97.x |
Metabolic | 250.1-250.3 | E08.00, E08.10, E08.649, E09.00, E09.10, E09.649, E11.00, E11.10, E11.649, E13.00, E13.10, E13.649, E08.01, E08.11, E08.641, E09.01, E09.11, E09.641, E11.01, E11.11, E11.641, E13.01, E13.11, E13.641 |
To assess for possible medication-related adverse events | ||
Hypoglycemia | 251.0, 251.2 | E11.64 |
Nausea | 787.0x | R11.xx |
Edema | 782 | R60.x |
Urinary tract infection | 599.0 | N39.0 |
aUnless otherwise specified.
aDCSI = adapted Diabetes Complications Severity Index; CPT-4 = Current Procedural Terminology, 4th Edition; ICD-9-CM = International Classification of Diseases, Ninth Revision, Clinical Modification; ICD-10-CM = International Classification of Diseases, Tenth Revision, Clinical Modification